Put Options Transactions Made in Q1 2024 in Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS) during Q1 2024. The information is specifically focused on institutions that hold put options of Arbutus Biopharma Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
PUT |
81.9K+ 330.24% |
$185K - $239K
|
107K
$339K
|
|
|
May 10, 2024
Q1 2024
|
Citigroup Inc
|
BUY
|
PUT |
55.6K+ 30.99% |
$126K - $162K
|
235K
$747K
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
PUT |
-63.3K- 78.83% |
$143K - $185K
|
17K
$54.1K
|
|
|
May 15, 2024
Q1 2024
|
Centiva Capital, LP
New York, NY |
SELL
|
PUT |
-563K- 75.01% |
$1.27M - $1.64M
|
187K
$596K
|